Literature DB >> 7717455

Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.

H Kitamura1, Y Kameda, N Nakamura, Y Nakatani, Y Inayama, M Iida, K Noda, N Ogawa, T Shibagaki, M Kanisawa.   

Abstract

To elucidate the pathogenesis of bronchioloalveolar lung carcinoma (BAC), we evaluated the lesion size, growth fraction, and p53 overexpression of atypical adenomatous hyperplasia (AAH) and early stage BAC. AAH was classified as showing low grade or high grade atypia. AAH-like carcinoma, presumably very early stage BAC, was distinguished from AAH in that it exhibited remarkable atypia suggestive of malignant potential and from overt BAC in that it lacked unequivocal malignant features, including invasive/destructive growth. The growth fraction was determined immunohistochemically in terms of the Ki-67 labeling index. The overexpression of p53 was evaluated by assessing the nuclear accumulation of immunoreactive p53 protein. Both the lesion size and the growth fraction increased from low grade AAH, to high grade AAH, to AAH-like carcinoma, and to overt adenocarcinoma. The overexpression of p53 in AAH-like carcinoma was similar to that in overt adenocarcinoma and was more frequent than that in AAH. Our findings indicate that AAH, AAH-like carcinoma, and overt BAC represent different categories, although the cellular events occurring in these lesions presumably represent a continuous spectrum of the changes that are reflected in the cytomorphology and lesion size. The findings here suggest that AAH and AAH-like carcinomas constitute a population of heterogeneous lesions representing different steps toward overt BAC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7717455      PMCID: PMC1869251     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  37 in total

Review 1.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

2.  Little missed markers and Ki-67.

Authors:  R Schwarting
Journal:  Lab Invest       Date:  1993-06       Impact factor: 5.662

3.  Atypical adenomatous hyperplasia of the lung and its differentiation from adenocarcinoma. Characterization of atypical cells by morphometry and multivariate cluster analysis.

Authors:  M Mori; R Chiba; T Takahashi
Journal:  Cancer       Date:  1993-10-15       Impact factor: 6.860

4.  p53 protein accumulates frequently in early bronchial neoplasia.

Authors:  W P Bennett; T V Colby; W D Travis; A Borkowski; R T Jones; D P Lane; R A Metcalf; J M Samet; Y Takeshima; J R Gu
Journal:  Cancer Res       Date:  1993-10-15       Impact factor: 12.701

5.  Detection of p53 overexpression in routinely paraffin-embedded tissue of human carcinomas using a novel target unmasking fluid.

Authors:  F M van den Berg; I O Baas; M M Polak; G J Offerhaus
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

6.  Concurrent p53 expression in bronchial dysplasias and squamous cell lung carcinomas.

Authors:  K Nuorva; Y Soini; D Kamel; H Autio-Harmainen; L Risteli; J Risteli; K Vähäkangas; P Pääkkö
Journal:  Am J Pathol       Date:  1993-03       Impact factor: 4.307

7.  c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.

Authors:  Z H Li; J Zheng; L M Weiss; D Shibata
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

8.  Immunohistochemical study of p53 in human lung carcinomas.

Authors:  E Brambilla; S Gazzeri; D Moro; C Caron de Fromentel; V Gouyer; M Jacrot; C Brambilla
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

9.  Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.

Authors:  T Hirano; B Franzén; H Kato; Y Ebihara; G Auer
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

10.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

View more
  14 in total

1.  Tumor extension and cell proliferation in adenocarcinomas of the lung.

Authors:  M Shoji; Y Dobashi; S Morinaga; S X Jiang; T Kameya
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

2.  Analysis of p21Waf1/Cip1 expression in normal, premalignant, and malignant cells during the development of human lung adenocarcinoma.

Authors:  H Hayashi; H Miyamoto; T Ito; Y Kameda; N Nakamura; Y Kubota; H Kitamura
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

3.  Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.

Authors:  Gen Yamada; Masaki Murata; Akira Takasawa; Masanori Nojima; Yuki Mori; Norimasa Sawada; Hiroki Takahashi
Journal:  Med Mol Morphol       Date:  2016-02-12       Impact factor: 2.309

4.  Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adenomatous hyperplasia.

Authors:  R Nakahara; T Yokose; K Nagai; Y Nishiwaki; A Ochiai
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

5.  Bronchioloalveolar neoplasia.

Authors:  Hitoshi Kitamura; Koji Okudela
Journal:  Int J Clin Exp Pathol       Date:  2010-11-12

6.  Proliferative activity and p53 protein accumulation correlate with early invasive trend, and apoptosis correlates with differentiation grade in oesophageal squamous cell carcinomas.

Authors:  K Ohashi; T Nemoto; Y Eishi; A Matsuno; K Nakamura; K Hirokawa
Journal:  Virchows Arch       Date:  1997-02       Impact factor: 4.064

7.  Growth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia.

Authors:  Hanako Sato; Takuya Yazawa; Takehisa Suzuki; Hiroaki Shimoyamada; Koji Okudela; Masaichi Ikeda; Kenji Hamada; Hisafumi Yamada-Okabe; Masayuki Yao; Yoshinobu Kubota; Takashi Takahashi; Hiroshi Kamma; Hitoshi Kitamura
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

8.  Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer.

Authors:  H Kawana; J Tamaru; T Tanaka; A Hirai; Y Saito; M Kitagawa; A Mikata; K Harigaya; T Kuriyama
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung.

Authors:  Julien D F Licchesi; William H Westra; Craig M Hooker; Emi O Machida; Stephen B Baylin; James G Herman
Journal:  Carcinogenesis       Date:  2008-02-28       Impact factor: 4.944

10.  Monoclonality of atypical adenomatous hyperplasia of the lung.

Authors:  S Niho; T Yokose; K Suzuki; T Kodama; Y Nishiwaki; K Mukai
Journal:  Am J Pathol       Date:  1999-01       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.